Company Profile: Recursion Pharmaceuticals

Phenotypic drug screening with AI techniques

The full version of this company profile is available to members of:

Accelerating Materials Innovation
Digital Health and Wellness
Digital Transformation
Emerging Ecosystems in Agrifood and Health
Industrial Big Data and Analytics
Materials Design and Manufacturing

Categories	Deep learning
Competitors	Atomwise, Numerate, Notable Labs, Cloud Pharmaceuticals
Relationships	Takeda Pharmaceutical (Customer) Sanofi (Customer)

Strategy & Markets

The company develops a phenotypic, high-throughput drug screening platform to identify drug targets for genetic diseases,...

Related Research
Last Update: April 24, 2020

Date	Type	Title
April 24, 2020	Technology	AI for Drug Discovery
April 03, 2020	Technology	Deep Learning
December 04, 2019	Technology	Computer Vision
July 08, 2019	Technology	Phenotyping
May 30, 2019	Technology	Computer Vision
October 04, 2018	Technology	Human Genomics
June 08, 2018	Technology	AI for Drug Discovery
May 08, 2018	Technology	Deep Learning
May 07, 2018	State of the Market Report	The Rise of AI in Computer Vision

About Lux Research

Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.

Already a Lux Client?

Interested in Learning More?

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 20 280 7900

For APAC (Singapore)
+65 6592-6978